Back
Share

Drugs and Drug Candidates

Drugs and Drug Candidates is Scopus-indexed, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).

ISSN 2813-2998Verify ISSN ↗

Publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Scopus · Not RankedOpen Access
2
Indexed in
major indexes

Cost to publish: Checking DOAJ for article charges…

ScopusElsevier Scopus
Status
Not Ranked
Coverage
2022–present
Source type
Journal
Open access
No
⚠ Scopus has not published a CiteScore for this journal in the current release — it may be newly indexed and not yet evaluated. Confirm its current status directly on Scopus before submitting.
View this source on Scopus.com
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Not listed in Web of Science.
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Is Drugs and Drug Candidates indexed in Scopus? Listed in Scopus, coverage 2022–present, but Scopus has not published a current CiteScore for this title — it may be newly indexed and not yet evaluated. Confirm its active status directly with Scopus before submitting.

What is the impact factor of Drugs and Drug Candidates? Drugs and Drug Candidates has no Journal Impact Factor — JIF is published only for Web of Science SCIE and SSCI titles — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.

Is Drugs and Drug Candidates in Web of Science? No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).

Is Drugs and Drug Candidates open access? Yes — it is an open-access journal, listed in DOAJ.

Impact & reach — open metrics via OpenAlex

18
h-index
11.31
2-yr mean citations
30
i10-index
211
works indexed
2,343
total citations
Papers published per year
0501002022: 5 papers520222023: 48 papers4820232024: 48 papers4820242025: 61 papers6120252026: 49 papers so far492026*

Drugs and Drug Candidates published 61 papers in 2025. 2026* is the year so far.

Main topics
Computational Drug Discovery MethodsEssential Oils and Antimicrobial ActivityNatural product bioactivities and synthesisSARS-CoV-2 and COVID-19 Research

h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-09-24.

Integrity signals — indicators, not proof of misconduct

  • Scopus statusActive
  • Retracted papers 2 · 9.5 per 1,000 papers

Retractions and authorship from OpenAlex; Scopus status from the Scopus source list. A signal marks something to look at more closely; it is not a finding against the journal.

Official sources & links

Related journals

← Back to Journal Finder

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.